Published in Thromb Diath Haemorrh on August 31, 1969
Interaction of platelets with bacterial endotoxins. Agents Actions (1983) 0.92
Intravascular coagulation in fulminant meningococcemia. Ann Intern Med (1967) 1.86
Health and re-employment in a two year follow up of long term unemployed. J Epidemiol Community Health (1993) 1.65
Detecting hypertension: screening versus case finding in Norway. BMJ (1991) 1.41
[Incidents in health services--prevention and management]. Tidsskr Nor Laegeforen (2000) 1.39
Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. Br J Haematol (1969) 1.34
Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol (1969) 1.32
Synthesis of donor type gamma-G-globulin following thymus transplantation in hypo-gamma-globulinaemia with severe lymphocytopenia. Scand J Haematol (1966) 1.20
A new type of inclusion bodies in lymphocytes. Scand J Haematol (1968) 1.16
The blood clotting properties of rabbit peritoneal leukocytes in vitro. Thromb Diath Haemorrh (1967) 1.15
Consumption of serum factors and prothrombin during intravascular clotting in rabbits. Scand J Haematol (1966) 0.97
Platelet surface charge and aggregation. Effects of polyelectrolytes. Thromb Diath Haemorrh (1969) 0.92
Factor VIII (AHG) levels in 1016 regular blood donors. The effects of age, sex, and ABO blood groups. Scand J Clin Lab Invest (1976) 0.91
Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies. Thromb Diath Haemorrh (1966) 0.91
Pathogenesis of disseminated intravascular coagulation. Hamatol Bluttransfus (1970) 0.87
Further evidence that thrombin-activation of Factor 8 is an essential step in intrinsic clotting. Scand J Clin Lab Invest (1965) 0.86
Platelets and the triggering mechanism of intravascular coagulation. Br J Haematol (1970) 0.86
Experimental thrombocytopenia induced by Busulphan (Myleran) in rabbits: extremely low platelet levels and intact plasma clotting system. Thromb Diath Haemorrh (1968) 0.85
[Use of fibrin glue in the prevention of leakage in pancreatico-jejunal anastomoses]. Acta Chir Iugosl (2002) 0.84
Effects of thorium dioxide upon blood clotting and platelets. II. In vivo studies in rabbits. Thromb Diath Haemorrh (1966) 0.83
MI--sometimes a blessing in disguise. Scand J Prim Health Care (1988) 0.81
Preservation of coagulation factors V and VIII during collection and subsequent storage of bank blood in ACD-A and CPD solutions. Vox Sang (1973) 0.81
Hereditary thrombocytopenia with excessively prolonged bleeding time. Scand J Haematol (1969) 0.81
Relation between drug utilization and morbidity pattern: antihypertensive drugs. Acta Med Scand Suppl (1984) 0.80
The environmental chemical tributyltin chloride (TBT) shows both estrogenic and adipogenic activities in mice which might depend on the exposure dose. Toxicol Appl Pharmacol (2011) 0.79
An attempt at predicting postoperative deep vein thrombosis by preoperative coagulation studies in patients undergoing total hip replacement. Thromb Haemost (1980) 0.79
Evidence that platelets may continue to circulate after phagocytosis of particles. Thromb Diath Haemorrh (1968) 0.79
Continuous hemostasis and continuous intravascular clotting: fact or myth? Thromb Diath Haemorrh Suppl (1966) 0.78
Plasma fibrinogen levels in 1,016 regular blood donors. I. The influence of age and sex on mean values and percentiles. Vox Sang (1974) 0.78
Rabbit factor V: different effects of thrombin and venom, a source of error in assay. Am J Physiol (1966) 0.78
Neuraminidase injections in rabbits. Reduced platelet surface charge, aggregation and thrombocytopenia. Thromb Diath Haemorrh (1973) 0.78
Decrease in platelet surface charge during phagocytosis of polystyrene latex particles or thorium dioxide. Scand J Haematol (1972) 0.77
Intravascular coagulation with generalized Shwartzman reaction induced by a heparin-like anticoagulant (Liquoid). Thromb Diath Haemorrh (1967) 0.77
[The use of hospital beds in an internal medicine department. A prospective study]. Tidsskr Nor Laegeforen (1966) 0.77
Influence of aggregating agents on electrophoretic mobility of blood platelets from health individuals and from patients with cardiovascular diseases. Lancet (1968) 0.77
Alternatives to animal experimentation for hormonal compounds research. Genes Nutr (2009) 0.76
Ring-shaped nuclei of granulocytes in a patient with acute erythroleukaemia. Scand J Haematol (1969) 0.76
The laboratory diagnosis of low-graded disseminated intravascular coagulation. A study in rabbits. Scand J Haematol (1973) 0.76
[Waiting lists and priorities]. Tidsskr Nor Laegeforen (1989) 0.75
[Regionalization of hospitals in Oslo]. Tidsskr Nor Laegeforen (1989) 0.75
The effect of endotoxin on factor VII in rats: in vivo and in vitro observations. Scand J Clin Lab Invest (1966) 0.75
[The disease and death of Olaf Bull. Thoughts about alcohol, disease and creativity]. Tidsskr Nor Laegeforen (1989) 0.75
[About a comprehensive pseudonymous registry]. Tidsskr Nor Laegeforen (1994) 0.75
[Health costs analysis of hemophilia in Norway]. Tidsskr Nor Laegeforen (1980) 0.75
[Should research be done at peripheral hospitals?]. Tidsskr Nor Laegeforen (1990) 0.75
[The key question in terminal care: when is the right time?]. Tidsskr Nor Laegeforen (1979) 0.75
[Cardiovascular program in Oppland County and Sogn and Fjordane. A summary of ideas and organization]. Tidsskr Nor Laegeforen (1987) 0.75
Interventional research in primary health care for the elderly. Scand J Prim Health Care (1985) 0.75
[Can readmissions be prevented? 1-year data from a medical ward in Oslo]. Tidsskr Nor Laegeforen (1987) 0.75
[Highly specialized medicine. How to assign the tasks?]. Tidsskr Nor Laegeforen (1992) 0.75
[Supply and use of health services--what can we learn from the difference between the counties of Oslo and Akershus?]. Tidsskr Nor Laegeforen (1982) 0.75
Panel discussion: Health services research in the 1980's: organization and possibilities for inter-Nordic cooperation. Scand J Soc Med Suppl (1984) 0.75
[Acute myelogenous leukemia. When the choice is between a good and a bad death]. Sykepleien (1986) 0.75
[Treatment for all or health for all?]. Tidsskr Nor Laegeforen (1990) 0.75
[Autopsy of 100 patients from nursing and old age homes in Oslo. 1) How correct are the clinical diagnoses? 2) What are the causes of death in aged patients?]. Tidsskr Nor Laegeforen (1984) 0.75
[Treatment of myocardial infarction--current status at Norwegian hospitals]. Tidsskr Nor Laegeforen (1990) 0.75
[Self perception as an elderly]. Tidsskr Nor Laegeforen (1998) 0.75
[A forgotten Norwegian pioneer work]. Tidsskr Nor Laegeforen (1998) 0.75
[Day surgery--yesterday and today]. Tidsskr Nor Laegeforen (1989) 0.75
[Terminal care--the Nobel Prize and new perspectives]. Tidsskr Nor Laegeforen (1979) 0.75
[Ambulance helicopters in the mountains. An evaluation of the 1-year activity at the Dombås base]. Tidsskr Nor Laegeforen (1991) 0.75
[Acute myelogenous leukemia in the adult. Is it right to give maximally potent treatment in early recurrence?]. Tidsskr Nor Laegeforen (1985) 0.75
[Physician's role]. Tidsskr Nor Laegeforen (1998) 0.75
[The aged patient]. Sykepleien (1982) 0.75
What is the economic impact of secondary prevention to society? Eur Heart J (1986) 0.75
[The future is light--there are only three problems]. Tidsskr Nor Laegeforen (2000) 0.75
Inequities in medical care: consequences for health. Scand J Soc Med Suppl (1984) 0.75
Physical activity, health and health economics. Scand J Soc Med Suppl (1982) 0.75
[Aplastic crises in the course of hereditary spherocytosis]. Tidsskr Nor Laegeforen (1997) 0.75
[Hospital services. Sectorization in Oslo from the nurses' viewpoint]. Sykepleien (1989) 0.75
Expenditures on health care in the last year of life. Int J Health Plann Manage (1990) 0.75
[Private and public medical care in the Scandinavian countries]. Nord Med (1986) 0.75
Iron-resistant hypochromic anemia in a Scandinavian family: heterozygous beta-thalassemia. Acta Med Scand (1969) 0.75
[Differences in the treatment plans of hospitals. Use of antidiabetics and selected cardiovascular drugs at 20 hospitals]. Tidsskr Nor Laegeforen (1980) 0.75
[Testing the local health care measures]. Tidsskr Nor Laegeforen (1995) 0.75
Is high technology medicine a threat to health care? Ann Med (1992) 0.75
[The cardiovascular project in Oppland County 1982-84. A quasi-experimental study]. Tidsskr Nor Laegeforen (1987) 0.75
[The child with bronchial obstruction in general practice. Need for better follow-up]. Tidsskr Nor Laegeforen (1992) 0.75
Inequities in short-stay somatic hospital care in Norway. Scand J Soc Med Suppl (1984) 0.75
Numerous lipid-containing vacuoles in the myeloblasts of two patients with acute leukaemia. Scand J Haematol (1969) 0.75
[Some things were better before--how can we make use of them?]. Tidsskr Nor Laegeforen (2001) 0.75
[The role of the thrombocytes in the induction of intravascular coagulation]. Bibl Haematol (1969) 0.75
Health services: finding out what is wrong--and trying to put it right. World Health Forum (1988) 0.75
[Health care consumption in the last year of life. Part of total health care consumption]. Tidsskr Nor Laegeforen (1988) 0.75
[Leadership in hospitals--what happened to charisma and vision?]. Tidsskr Nor Laegeforen (1992) 0.75
[Physician's role]. Lakartidningen (1999) 0.75
The relationship between action and research in health policy. Soc Sci Med A (1981) 0.75
[Longevity among Norwegian Adventists 1960-1977: a message of life style and health?]. Tidsskr Nor Laegeforen (1981) 0.75
[Physical activity, health and health economics]. Tidsskr Nor Laegeforen (1980) 0.75
[Norwegian medicine in the year 2000]. Tidsskr Nor Laegeforen (1981) 0.75
[Physical activity and health in the elderly--walk on!]. Tidsskr Nor Laegeforen (2000) 0.75
[Physical inactivity--the forgotten risk factor]. Tidsskr Nor Laegeforen (1997) 0.75
[Kipling's poem "If" and our secret debate on bone marrow transplantation]. Tidsskr Nor Laegeforen (1993) 0.75
[Policlinic and hospital department--1 unit]. Tidsskr Nor Laegeforen (1978) 0.75
[Cooperation between regional and central hospitals--how to achieve the best results?]. Tidsskr Nor Laegeforen (1992) 0.75
Intravascular coagulation with generalized Shwartzman reaction induced by liquoid: lack of protection by extreme thrombocytopenia. Thromb Diath Haemorrh (1968) 0.75
[Terminal care, not life help]. Tidsskr Nor Laegeforen (2000) 0.75